{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:10:03Z","timestamp":1761977403525,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"CJ CheilJedang Corporation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.vaccine.2013.08.071","type":"journal-article","created":{"date-parts":[[2013,9,8]],"date-time":"2013-09-08T03:33:32Z","timestamp":1378611212000},"page":"5239-5242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adults"],"prefix":"10.1016","volume":"31","author":[{"given":"Nak-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyoeng Gyun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Su","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baik-Lin","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoung-don","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2013.08.071_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7774\/cevr.2012.1.1.9","article-title":"Milestones in history of adult vaccination in Korea","volume":"7\/1","author":"Oh","year":"2012","journal-title":"Clin Exp Vaccin Res"},{"issue":"June 25 (24)","key":"10.1016\/j.vaccine.2013.08.071_bib0010","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.289.24.3278","article-title":"US military smallpox vaccination program experience","volume":"289","author":"Grabenstein","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"July 15 (2)","key":"10.1016\/j.vaccine.2013.08.071_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/375824","article-title":"Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.08.071_bib0020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat Med"},{"issue":"March 4 (10)","key":"10.1016\/j.vaccine.2013.08.071_bib0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"issue":"January 29\u2013February 4 (9457)","key":"10.1016\/j.vaccine.2013.08.071_bib0030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","volume":"365","author":"Greenberg","year":"2005","journal-title":"Lancet"},{"issue":"May 9 (25)","key":"10.1016\/j.vaccine.2013.08.071_bib0035","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"issue":"August 14 (33)","key":"10.1016\/j.vaccine.2013.08.071_bib0040","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1016\/j.vaccine.2007.05.044","article-title":"Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults","volume":"25","author":"Kim","year":"2007","journal-title":"Vaccine"},{"year":"2007","series-title":"Approval Letter \u2013 ACAM2000","author":"US-FDA","key":"10.1016\/j.vaccine.2013.08.071_bib0045"},{"key":"10.1016\/j.vaccine.2013.08.071_bib0050","unstructured":"CJ-Corporation. Investigator's Brochure for CJ-50300, 2009."},{"issue":"August 16 (36)","key":"10.1016\/j.vaccine.2013.08.071_bib0055","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1016\/j.vaccine.2010.06.063","article-title":"A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers","volume":"28","author":"Jang","year":"2010","journal-title":"Vaccine"},{"issue":"June 22 (RR-10)","key":"10.1016\/j.vaccine.2013.08.071_bib0060","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001","volume":"50","author":"Rotz","year":"2001","journal-title":"MMWR Recomm Rep"},{"year":"2007","series-title":"ACAM2000 Smallpox Vaccine Vaccines and Related Biological Products Advisory Committee (VRBPAC) Briefing Document","author":"US-FDA","key":"10.1016\/j.vaccine.2013.08.071_bib0065"},{"issue":"September 15 (6)","key":"10.1016\/j.vaccine.2013.08.071_bib0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1086\/432765","article-title":"Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial","volume":"192","author":"Kim","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.08.071_bib0075","doi-asserted-by":"crossref","first-page":"e4087","DOI":"10.1371\/journal.pone.0004087","article-title":"Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers","volume":"3","author":"Bossi","year":"2008","journal-title":"PloS One"},{"issue":"October 1 (7)","key":"10.1016\/j.vaccine.2013.08.071_bib0080","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/423851","article-title":"Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus","volume":"190","author":"Orr","year":"2004","journal-title":"J Infect Dis"},{"issue":"June 25 (24)","key":"10.1016\/j.vaccine.2013.08.071_bib0085","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"November 15 (10)","key":"10.1016\/j.vaccine.2013.08.071_bib0090","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.08.071_bib0095","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"March 3","key":"10.1016\/j.vaccine.2013.08.071_bib0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"el-Ad","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.071_bib0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/505505","article-title":"Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus","volume":"194","author":"Kim","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T08:32:05Z","timestamp":1539419525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":21,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0264410X13011833"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}